This year’s Met Gala was as glamorous as ever, but beyond the dazzling outfits, another trend emerged—dramatic weight loss among celebrities. Speculation swirled about whether Ozempic, a drug originally for diabetes but now used for weight management, played a role in their slimmer appearances. Doctors have shared insights, analyzing which stars might be using it and how.
Mindy Kaling’s toned figure caught attention, but she has been vocal about her fitness routine, including hiking and weightlifting. She insists her weight loss comes from discipline, not shortcuts. Still, some experts suspect she may have incorporated medications like Ozempic to enhance results before the event.
Nicole Kidman, known for her timeless elegance, has always prioritized health. She runs, practices yoga, and follows an 80% healthy diet, allowing herself occasional indulgences. While Ozempic rumors persist, her long-standing habits suggest her slim frame is more about consistency than quick fixes.
View this post on Instagram
Nicole Scherzinger stunned in a sleek gown, leading to questions about possible “Ozempic face”—a term for facial changes from rapid weight loss. However, Scherzinger credits her shape to high-intensity workouts and mindful eating, though she admits to a weakness for cakes and chocolate.
Vera Wang’s strikingly thin look sparked concern, with experts debating whether age or medication contributed. Wang, however, has shared her active lifestyle, proving she stays fit through movement, even if she jokes about her love-hate relationship with treadmills.
View this post on Instagram
Priyanka Chopra’s balanced physique led doctors to theorize she might be using Ozempic in moderation, combined with training. Chopra has embraced her body confidently, especially after film-prep workouts that made her appreciate her strength.
The Met Gala’s underlying theme this year? The fine line between natural wellness and the pressures of Hollywood beauty standards. Whether through hard work, medical aid, or both, these stars navigate their health journeys under constant public scrutiny.
